Ocaliva (Page 7 of 7)

PRINCIPAL DISPLAY PANEL — 5 mg Tablet Bottle Label

NDC 69516-005-30
Rx only

OCALIVA®
(obeticholic acid) tablets

5 mg

30 tabletsIntercept

PRINCIPAL DISPLAY PANEL -- 5 mg Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 mg Tablet Bottle Label

NDC 69516-010-30
Rx only

OCALIVA®
(obeticholic acid) tablets

10 mg

30 tabletsIntercept

PRINCIPAL DISPLAY PANEL -- 10 mg Tablet Bottle Label
(click image for full-size original)
OCALIVA obeticholic acid tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69516-005
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
OBETICHOLIC ACID (OBETICHOLIC ACID) OBETICHOLIC ACID 5 mg
Inactive Ingredients
Ingredient Name Strength
MICROCRYSTALLINE CELLULOSE
SODIUM STARCH GLYCOLATE TYPE A POTATO
MAGNESIUM STEARATE
POLYVINYL ALCOHOL, UNSPECIFIED
TITANIUM DIOXIDE
POLYETHYLENE GLYCOL 3350
TALC
FERRIC OXIDE YELLOW
Product Characteristics
Color YELLOW Score no score
Shape ROUND Size 8mm
Flavor Imprint Code INT;5
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:69516-005-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA207999 05/27/2016
OCALIVA obeticholic acid tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69516-010
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
OBETICHOLIC ACID (OBETICHOLIC ACID) OBETICHOLIC ACID 10 mg
Inactive Ingredients
Ingredient Name Strength
MICROCRYSTALLINE CELLULOSE
SODIUM STARCH GLYCOLATE TYPE A POTATO
MAGNESIUM STEARATE
POLYVINYL ALCOHOL, UNSPECIFIED
TITANIUM DIOXIDE
POLYETHYLENE GLYCOL 3350
TALC
FERRIC OXIDE YELLOW
Product Characteristics
Color YELLOW Score no score
Shape TRIANGLE Size 8mm
Flavor Imprint Code INT;10
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:69516-010-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA207999 05/27/2016
Labeler — Intercept Pharmaceuticals Inc (966658416)
Establishment
Name Address ID/FEI Operations
Pharmacia & Upjohn Company LLC 618054084 ANALYSIS (69516-005), ANALYSIS (69516-010), API MANUFACTURE (69516-005), API MANUFACTURE (69516-010)

Revised: 10/2022 Intercept Pharmaceuticals Inc

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.